MT
MucoLife Therapeutics
Sweden · Biotech · Healthtech
Developing inhaled peptide medicines to clear mucus obstructions in lung disease.
Product
MucoLife Therapeutics is a Gothenburg-based biopharmaceutical company developing treatments for obstructed airways. Its lead candidate, MLT-001, is an inhaled peptide designed to dissolve mucus plugs associated with chronic obstructive pulmonary disease and other muco-obstructive conditions.
MLT-001 is an investigational, preclinical compound. The company is developing its production and purification processes as it works toward clinical studies.
Funding history
3 rounds · 3 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Vinnova ScaleGla grant | SEK 1M | Vinnova — Participant | |
| Vinnova MUCO-Bridge grant | SEK 500K | Vinnova — Participant | |
| Medtech4Health nebulization planning grant | SEK 200K | Vinnova — Participant |